Market Research Assistance

On the Web
Refine Result

By Date

Last Month
Last 3 Months
Last 6 Months
Last Year
Last 2 Years

By Price

< $1000

Gaucher Drugs Market Research Reports


Gaucher's Disease-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2016

By Delve Insight
"...... ey objective of the Gaucher's Disease Report is to understand the market and pipeline status of the drugs around the Gaucher's Disease to explore the generic development opportunities, licensing opportunities and to gain competitive advantage on desi......"

United States Gaucher Disease Industry 2016 Market Research Report

By QYResearch Group
"...... in structure. The Gaucher Disease market analysis is provided for the United States markets including development trends, competitive landscape analysis, and key regions development status. Development policies and plans are discussed ......"

Global Gaucher Disease Market Research Report 2021

By QYResearch Group
"...... lobal market, with sales, price, revenue and market share for each manufacturer, covering - Sanofi - Shire - Actelion Pharma - Pfizer Market Segment by Region, this report splits Global into several key Regions, wit......"

Global and China Gaucher Disease Sales Market Report to 2020

By QYResearch Group
"...... ucher Disease in USA, EU, China, Japan, India and Southeast Asia, forecast to 2020, from 2011. Split by product types, with production, revenue, market share and price of each type, as well as the types and price of each type price for......"

Gaucher Disease - Pipeline Review, H1 2016

By Global Markets Direct
"...... nt, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press re......"

Gaucher Disease (GD) - Market Insights, Epidemiology and Market Forecast-2020

By Delve Insight
"...... ie: United States, EU5 (France, Germany, Italy, Spain, UK) and Japan. The Report covers the therapeutics market revenue; average cost of therapy, treatment practice and Gaucher Disease (GD) forecasted market share for ten years to 2020 segmented by ......"

Gaucher's Disease-Pipeline Insights, 2016

By Delve Insight
"...... ery, Pre-clinical, IND, Phase I, Phase II, Phase III and Preregistration. Report covers the product clinical trials information and other development activities including technology, licensing, collaborations, acquisitions, fundings, patent and USFDA......"

OpportunityAnalyzer: Gaucher Disease - Opportunity Analysis and Forecast to 2024

By GlobalData
"...... ales are expected to increase to $1.16 billion at a Compound Annual Growth Rate (CAGR) of 2.9%. The majority of these sales will continue to come from the US, which will represent approximately 56.2% of the GD market in the 7MM in 2024. GlobalData fo......"

EpiCast Report: Gaucher Disease - Epidemiology Forecast to 2024

By GlobalData
"...... roside (GC), as a result of the deficiency or limited activity of the enzyme glucocerebrosidase (GCase). This leads to the harmful accumulation of GC, which is also known as glucosylceramide, in the lysosomes, most commonly in the macrophages and mon......"

Gaucher's Disease - Pipeline Review, H2 2015

By Global Markets Direct
"...... rious stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the therapeutic......"